PALB2 and ovarian carcinoma: Indeed, it has to be underlined that, beyond breast and ovarian cancers, pathogenic variants in BRCA1 and BRCA2, as well as in CHEK2 and PALB2, have been associated with a higher risk of developing an increasing number of cancers.